Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Augmenta will invest in early stages of companies with unique products and strong growth potential. When portfolio companies have a fully developed product or service that is ready for commercialization, will Augmenta to leave their interests in portfolio companies. Exactly when this will happen will vary and depend on each company&s;s unique situation.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2010 | Adenovir Pharma | Venture Round | 0 |
6/2010 | Adenovir Pharma | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|